应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
NXTC Nextcure Inc.
盘后交易 12-05 16:47:43 EST
12.34
-0.39
-3.10%
盘后
12.34
+0.00
0.00%
16:10 EST
最高
12.81
最低
12.10
成交量
2.50万
今开
12.40
昨收
12.73
日振幅
5.58%
总市值
6,418万
流通市值
5,220万
总股本
520.33万
成交额
30.86万
换手率
0.59%
流通股本
423.22万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
NextCure宣布按纳斯达克规则以市场价格进行2150万美元的普通股私募投资
美股速递 · 11-12
NextCure宣布按纳斯达克规则以市场价格进行2150万美元的普通股私募投资
Nextcure, Inc.盘中异动 股价大跌6.70%报11.00美元
市场透视 · 10-22
Nextcure, Inc.盘中异动 股价大跌6.70%报11.00美元
Nextcure与先声药业宣布Sim0505(Cdh6 ADC)正在进行的1期临床试验扩展至美国
美股速递 · 10-16
Nextcure与先声药业宣布Sim0505(Cdh6 ADC)正在进行的1期临床试验扩展至美国
Nextcure, Inc.盘中异动 早盘急速下跌6.12%报6.24美元
市场透视 · 10-13
Nextcure, Inc.盘中异动 早盘急速下跌6.12%报6.24美元
Nextcure, Inc.盘中异动 早盘股价大涨5.36%
市场透视 · 10-10
Nextcure, Inc.盘中异动 早盘股价大涨5.36%
Nextcure, Inc.盘中异动 下午盘大幅跳水5.67%报5.42美元
市场透视 · 09-26
Nextcure, Inc.盘中异动 下午盘大幅跳水5.67%报5.42美元
Nextcure, Inc.盘中异动 早盘快速跳水5.58%报4.91美元
市场透视 · 08-06
Nextcure, Inc.盘中异动 早盘快速跳水5.58%报4.91美元
Nextcure, Inc.盘中异动 早盘快速跳水5.92%
市场透视 · 07-28
Nextcure, Inc.盘中异动 早盘快速跳水5.92%
Nextcure, Inc.盘中异动 早盘股价大涨5.58%报5.09美元
市场透视 · 07-17
Nextcure, Inc.盘中异动 早盘股价大涨5.58%报5.09美元
Nextcure, Inc.盘中异动 早盘股价大涨5.04%
市场透视 · 07-16
Nextcure, Inc.盘中异动 早盘股价大涨5.04%
Nextcure, Inc.盘中异动 早盘急速拉升5.27%
市场透视 · 07-14
Nextcure, Inc.盘中异动 早盘急速拉升5.27%
Nextcure, Inc.盘中异动 大幅下挫5.98%报0.440美元
市场透视 · 07-11
Nextcure, Inc.盘中异动 大幅下挫5.98%报0.440美元
Nextcure, Inc.盘中异动 早盘股价大涨8.03%
市场透视 · 07-09
Nextcure, Inc.盘中异动 早盘股价大涨8.03%
Nextcure, Inc.盘中异动 大幅下跌6.02%
市场透视 · 07-02
Nextcure, Inc.盘中异动 大幅下跌6.02%
Nextcure, Inc.盘中异动 早盘股价大涨5.56%
市场透视 · 06-30
Nextcure, Inc.盘中异动 早盘股价大涨5.56%
Nextcure, Inc.6月24日成交额为5.59万美元
市场透视 · 06-25
Nextcure, Inc.6月24日成交额为5.59万美元
Nextcure, Inc.6月23日成交额为12.28万美元
市场透视 · 06-24
Nextcure, Inc.6月23日成交额为12.28万美元
Nextcure, Inc.盘中异动 股价大涨7.67%
市场透视 · 06-20
Nextcure, Inc.盘中异动 股价大涨7.67%
Nextcure, Inc.6月17日成交额为17.52万美元
市场透视 · 06-18
Nextcure, Inc.6月17日成交额为17.52万美元
Nextcure, Inc.盘中异动 早盘快速上涨5.38%
市场透视 · 06-11
Nextcure, Inc.盘中异动 早盘快速上涨5.38%
加载更多
公司概况
公司名称:
Nextcure Inc.
所属市场:
NASDAQ
上市日期:
--
主营业务:
NextCure, Inc.于2015年9月在特拉华州注册成立,总部位于马里兰州贝尔茨维尔。 该公司是一家临床阶段的生物制药公司,致力于发现和开发新型的一流免疫药物,通过恢复正常的免疫功能来治疗癌症和其他免疫相关疾病。 通过其专有的功能性,集成式,免疫肿瘤学中的NextCure Discovery(“FIND-IO”)平台,公司研究各种免疫细胞,以发现和了解免疫细胞的靶标和结构成分及其功能影响,从而开发免疫组化。
发行价格:
--
{"stockData":{"symbol":"NXTC","market":"US","secType":"STK","nameCN":"Nextcure Inc.","latestPrice":12.335,"timestamp":1764968400000,"preClose":12.73,"halted":0,"volume":24986,"hourTrading":{"tag":"盘后","latestPrice":12.335,"preClose":12.335,"latestTime":"16:10 EST","volume":5,"amount":61.675000000000004,"timestamp":1764969004534},"delay":0,"floatShares":4232200,"shares":5203299,"eps":-23.867064,"marketStatus":"盘后交易","change":-0.395,"latestTime":"12-05 16:47:43 EST","open":12.4,"high":12.81,"low":12.1,"amount":308580.34818,"amplitude":0.055774,"askPrice":13.45,"askSize":100,"bidPrice":12.26,"bidSize":10,"shortable":3,"etf":0,"ttmEps":-23.867064,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1764982800000},"marketStatusCode":4,"adr":0,"adrRate":0,"listingDate":1557374400000,"exchange":"NASDAQ","adjPreClose":12.73,"preHourTrading":{"tag":"盘前","latestPrice":12.73,"preClose":12.73,"latestTime":"08:00 EST","volume":1,"amount":12.73,"timestamp":1764939601903},"postHourTrading":{"tag":"盘后","latestPrice":12.335,"preClose":12.335,"latestTime":"16:10 EST","volume":5,"amount":61.675000000000004,"timestamp":1764969004534},"volumeRatio":0.58441,"impliedVol":0.7756,"impliedVolPercentile":0.4257},"requestUrl":"/m/hq/s/NXTC","defaultTab":"news","newsList":[{"id":"1195873990","title":"NextCure宣布按纳斯达克规则以市场价格进行2150万美元的普通股私募投资","url":"https://stock-news.laohu8.com/highlight/detail?id=1195873990","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1195873990?lang=zh_cn&edition=full","pubTime":"2025-11-12 21:01","pubTimestamp":1762952473,"startTime":"0","endTime":"0","summary":"NextCure宣布按纳斯达克规则以市场价格进行2150万美元的普通股私募投资","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NXTC","BK4139"],"gpt_icon":0},{"id":"2577301174","title":"Nextcure, Inc.盘中异动 股价大跌6.70%报11.00美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2577301174","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577301174?lang=zh_cn&edition=full","pubTime":"2025-10-22 21:46","pubTimestamp":1761140817,"startTime":"0","endTime":"0","summary":"北京时间2025年10月22日21时46分,Nextcure, Inc.股票出现波动,股价急速跳水6.70%。截至发稿,该股报11.00美元/股,成交量7758股,换手率0.29%,振幅4.95%。Nextcure, Inc.股票所在的生物技术行业中,整体跌幅为0.03%。Nextcure, Inc.公司简介:NextCure Inc 是一家临床阶段的生物制药公司,致力于发现和开发新型、一流的免疫药物,通过恢复正常的免疫功能来治疗癌症和其他免疫相关疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251022214657973cba27&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251022214657973cba27&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LU0266512127.USD","BK4539","CRC","LU0456854461.SGD","NXTC","BK4213","BK4007"],"gpt_icon":1},{"id":"1161819600","title":"Nextcure与先声药业宣布Sim0505(Cdh6 ADC)正在进行的1期临床试验扩展至美国","url":"https://stock-news.laohu8.com/highlight/detail?id=1161819600","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1161819600?lang=zh_cn&edition=full","pubTime":"2025-10-16 20:07","pubTimestamp":1760616433,"startTime":"0","endTime":"0","summary":"Nextcure与先声药业宣布Sim0505(Cdh6 ADC)正在进行的1期临床试验扩展至美国","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","NXTC","02096","BK1583","BK4139"],"gpt_icon":0},{"id":"2575823365","title":"Nextcure, Inc.盘中异动 早盘急速下跌6.12%报6.24美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2575823365","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2575823365?lang=zh_cn&edition=full","pubTime":"2025-10-13 21:33","pubTimestamp":1760362397,"startTime":"0","endTime":"0","summary":"北京时间2025年10月13日21时33分,Nextcure, Inc.股票出现波动,股价急速跳水6.12%。截至发稿,该股报6.24美元/股,成交量1565股,换手率0.06%,振幅2.11%。Nextcure, Inc.股票所在的生物技术行业中,整体跌幅为0.46%。Nextcure, Inc.公司简介:NextCure Inc 是一家临床阶段的生物制药公司,致力于发现和开发新型、一流的免疫药物,通过恢复正常的免疫功能来治疗癌症和其他免疫相关疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251013213317a6b731c9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251013213317a6b731c9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0456854461.SGD","BK4139","LU0266512127.USD","NXTC","CRC","BK4213"],"gpt_icon":0},{"id":"2574926439","title":"Nextcure, Inc.盘中异动 早盘股价大涨5.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2574926439","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2574926439?lang=zh_cn&edition=full","pubTime":"2025-10-10 22:14","pubTimestamp":1760105671,"startTime":"0","endTime":"0","summary":"北京时间2025年10月10日22时14分,Nextcure, Inc.股票出现异动,股价急速拉升5.36%。Nextcure, Inc.股票所在的生物技术行业中,整体跌幅为0.26%。Nextcure, Inc.公司简介:NextCure Inc 是一家临床阶段的生物制药公司,致力于发现和开发新型、一流的免疫药物,通过恢复正常的免疫功能来治疗癌症和其他免疫相关疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202510102214319726ae20&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202510102214319726ae20&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0456854461.SGD","CRC","BK4213","NXTC","BK4139","LU0266512127.USD"],"gpt_icon":0},{"id":"2570078561","title":"Nextcure, Inc.盘中异动 下午盘大幅跳水5.67%报5.42美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2570078561","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2570078561?lang=zh_cn&edition=full","pubTime":"2025-09-26 02:31","pubTimestamp":1758825101,"startTime":"0","endTime":"0","summary":"北京时间2025年09月26日02时31分,Nextcure, Inc.股票出现异动,股价快速跳水5.67%。截至发稿,该股报5.42美元/股,成交量919股,换手率0.03%,振幅4.00%。Nextcure, Inc.股票所在的生物技术行业中,整体跌幅为1.09%。Nextcure, Inc.公司简介:NextCure Inc 是一家临床阶段的生物制药公司,致力于发现和开发新型、一流的免疫药物,通过恢复正常的免疫功能来治疗癌症和其他免疫相关疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025092602314195453089&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025092602314195453089&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4213","LU0456854461.SGD","BK4139","LU0266512127.USD","NXTC","CRC"],"gpt_icon":0},{"id":"2557308797","title":"Nextcure, Inc.盘中异动 早盘快速跳水5.58%报4.91美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557308797","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557308797?lang=zh_cn&edition=full","pubTime":"2025-08-06 22:07","pubTimestamp":1754489249,"startTime":"0","endTime":"0","summary":"北京时间2025年08月06日22时07分,Nextcure, Inc.股票出现波动,股价急速跳水5.58%。截至发稿,该股报4.91美元/股,成交量2009股,换手率0.08%,振幅1.44%。Nextcure, Inc.股票所在的生物技术行业中,整体跌幅为0.14%。Nextcure, Inc.公司简介:NextCure Inc 是一家临床阶段的生物制药公司,致力于发现和开发新型、一流的免疫药物,通过恢复正常的免疫功能来治疗癌症和其他免疫相关疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080622072994d38a1e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080622072994d38a1e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRC","LU0456854461.SGD","BK4139","NXTC","LU0266512127.USD","BK4213"],"gpt_icon":0},{"id":"2554266777","title":"Nextcure, Inc.盘中异动 早盘快速跳水5.92%","url":"https://stock-news.laohu8.com/highlight/detail?id=2554266777","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2554266777?lang=zh_cn&edition=full","pubTime":"2025-07-28 22:06","pubTimestamp":1753711594,"startTime":"0","endTime":"0","summary":"北京时间2025年07月28日22时06分,Nextcure, Inc.股票出现异动,股价急速下挫5.92%。Nextcure, Inc.股票所在的生物技术行业中,整体涨幅为0.12%。Nextcure, Inc.公司简介:NextCure Inc 是一家临床阶段的生物制药公司,致力于发现和开发新型、一流的免疫药物,通过恢复正常的免疫功能来治疗癌症和其他免疫相关疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072822063497235a18&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072822063497235a18&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NXTC","BK4139","BK4213","LU0456854461.SGD","LU0266512127.USD","CRC"],"gpt_icon":0},{"id":"2552877904","title":"Nextcure, Inc.盘中异动 早盘股价大涨5.58%报5.09美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2552877904","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552877904?lang=zh_cn&edition=full","pubTime":"2025-07-17 22:39","pubTimestamp":1752763140,"startTime":"0","endTime":"0","summary":"北京时间2025年07月17日22时39分,Nextcure, Inc.股票出现波动,股价急速上涨5.58%。截至发稿,该股报5.09美元/股,成交量9969股,换手率0.43%,振幅2.92%。Nextcure, Inc.股票所在的生物技术行业中,整体涨幅为0.16%。Nextcure, Inc.公司简介:NextCure Inc 是一家临床阶段的生物制药公司,致力于发现和开发新型、一流的免疫药物,通过恢复正常的免疫功能来治疗癌症和其他免疫相关疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250717223900a6b013d2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250717223900a6b013d2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4213","BK4139","LU0456854461.SGD","NXTC","CRC","LU0266512127.USD"],"gpt_icon":0},{"id":"2551578126","title":"Nextcure, Inc.盘中异动 早盘股价大涨5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2551578126","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551578126?lang=zh_cn&edition=full","pubTime":"2025-07-16 21:42","pubTimestamp":1752673366,"startTime":"0","endTime":"0","summary":"北京时间2025年07月16日21时42分,Nextcure, Inc.股票出现波动,股价快速上涨5.04%。截至发稿,该股报5.00美元/股,成交量3915股,换手率0.17%,振幅0.00%。Nextcure, Inc.股票所在的生物技术行业中,整体涨幅为0.75%。Nextcure, Inc.公司简介:NextCure Inc 是一家临床阶段的生物制药公司,致力于发现和开发新型、一流的免疫药物,通过恢复正常的免疫功能来治疗癌症和其他免疫相关疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716214246a44ee475&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716214246a44ee475&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0266512127.USD","CRC","NXTC","BK4213","LU0456854461.SGD","BK4139"],"gpt_icon":0},{"id":"2551182316","title":"Nextcure, Inc.盘中异动 早盘急速拉升5.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2551182316","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551182316?lang=zh_cn&edition=full","pubTime":"2025-07-14 21:47","pubTimestamp":1752500848,"startTime":"0","endTime":"0","summary":"北京时间2025年07月14日21时47分,Nextcure, Inc.股票出现波动,股价大幅上涨5.27%。Nextcure, Inc.股票所在的生物技术行业中,整体涨幅为0.20%。Nextcure, Inc.公司简介:NextCure Inc 是一家临床阶段的生物制药公司,致力于发现和开发新型、一流的免疫药物,通过恢复正常的免疫功能来治疗癌症和其他免疫相关疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250714214729a6a8f749&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250714214729a6a8f749&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LU0266512127.USD","CRC","NXTC","BK4213","LU0456854461.SGD"],"gpt_icon":0},{"id":"2550952217","title":"Nextcure, Inc.盘中异动 大幅下挫5.98%报0.440美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550952217","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550952217?lang=zh_cn&edition=full","pubTime":"2025-07-11 23:01","pubTimestamp":1752246113,"startTime":"0","endTime":"0","summary":"北京时间2025年07月11日23时01分,Nextcure, Inc.股票出现异动,股价大幅下挫5.98%。截至发稿,该股报0.440美元/股,成交量2.3077万股,换手率0.08%,振幅4.23%。Nextcure, Inc.股票所在的生物技术行业中,整体跌幅为0.90%。Nextcure, Inc.公司简介:NextCure Inc 是一家临床阶段的生物制药公司,致力于发现和开发新型、一流的免疫药物,通过恢复正常的免疫功能来治疗癌症和其他免疫相关疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250711230154953eebb8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250711230154953eebb8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LU0266512127.USD","CRC","BK4213","NXTC","LU0456854461.SGD"],"gpt_icon":0},{"id":"2550658750","title":"Nextcure, Inc.盘中异动 早盘股价大涨8.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2550658750","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550658750?lang=zh_cn&edition=full","pubTime":"2025-07-09 21:31","pubTimestamp":1752067870,"startTime":"0","endTime":"0","summary":"北京时间2025年07月09日21时31分,Nextcure, Inc.股票出现波动,股价急速拉升8.03%。Nextcure, Inc.股票所在的生物技术行业中,整体涨幅为0.29%。Nextcure, Inc.公司简介:NextCure Inc 是一家临床阶段的生物制药公司,致力于发现和开发新型、一流的免疫药物,通过恢复正常的免疫功能来治疗癌症和其他免疫相关疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709213110a440798b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709213110a440798b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0456854461.SGD","CRC","BK4213","NXTC","BK4139","LU0266512127.USD"],"gpt_icon":0},{"id":"2548882385","title":"Nextcure, Inc.盘中异动 大幅下跌6.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2548882385","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548882385?lang=zh_cn&edition=full","pubTime":"2025-07-02 03:43","pubTimestamp":1751399014,"startTime":"0","endTime":"0","summary":"北京时间2025年07月02日03时43分,Nextcure, Inc.股票出现波动,股价快速跳水6.02%。Nextcure, Inc.股票所在的生物技术行业中,整体涨幅为0.44%。Nextcure, Inc.公司简介:NextCure Inc 是一家临床阶段的生物制药公司,致力于发现和开发新型、一流的免疫药物,通过恢复正常的免疫功能来治疗癌症和其他免疫相关疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025070203433497964830&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025070203433497964830&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRC","NXTC","LU0456854461.SGD","BK4139","BK4213","LU0266512127.USD"],"gpt_icon":0},{"id":"2547402097","title":"Nextcure, Inc.盘中异动 早盘股价大涨5.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2547402097","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2547402097?lang=zh_cn&edition=full","pubTime":"2025-06-30 21:42","pubTimestamp":1751290921,"startTime":"0","endTime":"0","summary":"北京时间2025年06月30日21时42分,Nextcure, Inc.股票出现波动,股价大幅拉升5.56%。Nextcure, Inc.股票所在的生物技术行业中,整体涨幅为0.13%。Nextcure, Inc.公司简介:NextCure Inc 是一家临床阶段的生物制药公司,致力于发现和开发新型、一流的免疫药物,通过恢复正常的免疫功能来治疗癌症和其他免疫相关疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506302142019794a97e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506302142019794a97e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRC","LU0266512127.USD","BK4213","LU0456854461.SGD","BK4139","NXTC"],"gpt_icon":0},{"id":"2546264555","title":"Nextcure, Inc.6月24日成交额为5.59万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2546264555","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546264555?lang=zh_cn&edition=full","pubTime":"2025-06-25 12:28","pubTimestamp":1750825707,"startTime":"0","endTime":"0","summary":"美东时间2025年6月24日,Nextcure, Inc.成交额为5.59万美元,成交额较昨日减少54.51%,当日成交量为11.86万股。Nextcure, Inc.于2025年6月24日跌0.91%,报0.466美元,该股过去5个交易日跌7.23%,年初至今跌39.6%,过去60日跌12.3%。该公司还在为其其他临床项目寻找合作伙伴,例如 NC525 和 NC318 以及用于慢性骨病的临床前非肿瘤项目 NC605 和用于阿尔茨海默病的 NC181。(以上内容为腾讯自选股基于公开消息,由程序或算法智能生成,仅作为用户看盘参考,不作为投资建议或交易依据。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250625122833a4bc9c6f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250625122833a4bc9c6f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4213","BK4139","LU0456854461.SGD","NXTC","CRC","LU0266512127.USD"],"gpt_icon":0},{"id":"2545147158","title":"Nextcure, Inc.6月23日成交额为12.28万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2545147158","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545147158?lang=zh_cn&edition=full","pubTime":"2025-06-24 12:27","pubTimestamp":1750739229,"startTime":"0","endTime":"0","summary":"美东时间2025年6月23日,Nextcure, Inc.成交额为12.28万美元,成交额较昨日增加58.84%,当日成交量为25.88万股。Nextcure, Inc.于2025年6月23日涨0.0%,报0.47美元,该股过去5个交易日跌30.98%,年初至今跌39.04%,过去60日跌11.65%。该公司还在为其其他临床项目寻找合作伙伴,例如 NC525 和 NC318 以及用于慢性骨病的临床前非肿瘤项目 NC605 和用于阿尔茨海默病的 NC181。(以上内容为腾讯自选股基于公开消息,由程序或算法智能生成,仅作为用户看盘参考,不作为投资建议或交易依据。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250624122712a71a8909&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250624122712a71a8909&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0266512127.USD","BK4139","CRC","NXTC","LU0456854461.SGD","BK4213"],"gpt_icon":0},{"id":"2544120763","title":"Nextcure, Inc.盘中异动 股价大涨7.67%","url":"https://stock-news.laohu8.com/highlight/detail?id=2544120763","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544120763?lang=zh_cn&edition=full","pubTime":"2025-06-20 21:31","pubTimestamp":1750426285,"startTime":"0","endTime":"0","summary":"北京时间2025年06月20日21时31分,Nextcure, Inc.股票出现异动,股价急速上涨7.67%。Nextcure, Inc.股票所在的生物技术行业中,整体涨幅为0.39%。Nextcure, Inc.公司简介:NextCure Inc 是一家临床阶段的生物制药公司,致力于发现和开发新型、一流的免疫药物,通过恢复正常的免疫功能来治疗癌症和其他免疫相关疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250620213125a714a4d5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250620213125a714a4d5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LU0266512127.USD","CRC","BK4213","NXTC","LU0456854461.SGD"],"gpt_icon":0},{"id":"2544941367","title":"Nextcure, Inc.6月17日成交额为17.52万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2544941367","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544941367?lang=zh_cn&edition=full","pubTime":"2025-06-18 12:12","pubTimestamp":1750219941,"startTime":"0","endTime":"0","summary":"美东时间2025年6月17日,Nextcure, Inc.成交额为17.52万美元,成交额较昨日减少90.31%,当日成交量为37.30万股。Nextcure, Inc.于2025年6月17日跌10.08%,报0.452美元,该股过去5个交易日跌17.91%,年初至今跌41.44%,过去60日跌20.79%。该公司还在为其其他临床项目寻找合作伙伴,例如 NC525 和 NC318 以及用于慢性骨病的临床前非肿瘤项目 NC605 和用于阿尔茨海默病的 NC181。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250618121230a70fb4c0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250618121230a70fb4c0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0266512127.USD","CRC","BK4213","BK4139","NXTC","LU0456854461.SGD"],"gpt_icon":0},{"id":"2542538864","title":"Nextcure, Inc.盘中异动 早盘快速上涨5.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2542538864","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542538864?lang=zh_cn&edition=full","pubTime":"2025-06-11 21:45","pubTimestamp":1749649550,"startTime":"0","endTime":"0","summary":"北京时间2025年06月11日21时45分,Nextcure, Inc.股票出现异动,股价大幅上涨5.38%。Nextcure, Inc.股票所在的生物技术行业中,整体跌幅为0.09%。Nextcure, Inc.公司简介:NextCure Inc 是一家临床阶段的生物制药公司,致力于发现和开发新型、一流的免疫药物,通过恢复正常的免疫功能来治疗癌症和其他免疫相关疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250611214550a703c4f6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250611214550a703c4f6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRC","NXTC","LU0456854461.SGD","BK4139","BK4213","LU0266512127.USD"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.nextcure.com","stockEarnings":[{"period":"1week","weight":-0.066},{"period":"1month","weight":0.3205},{"period":"3month","weight":1.6247},{"period":"6month","weight":1.1418},{"period":"1year","weight":-0.0775},{"period":"ytd","weight":0.3759}],"compareEarnings":[{"period":"1week","weight":0.0069},{"period":"1month","weight":0.0136},{"period":"3month","weight":0.0574},{"period":"6month","weight":0.1423},{"period":"1year","weight":0.1263},{"period":"ytd","weight":0.1677}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"NextCure, Inc.于2015年9月在特拉华州注册成立,总部位于马里兰州贝尔茨维尔。 该公司是一家临床阶段的生物制药公司,致力于发现和开发新型的一流免疫药物,通过恢复正常的免疫功能来治疗癌症和其他免疫相关疾病。 通过其专有的功能性,集成式,免疫肿瘤学中的NextCure Discovery(“FIND-IO”)平台,公司研究各种免疫细胞,以发现和了解免疫细胞的靶标和结构成分及其功能影响,从而开发免疫组化。","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":0.008161},{"month":2,"riseRate":0.166667,"avgChangeRate":0.025138},{"month":3,"riseRate":0.166667,"avgChangeRate":-0.063149},{"month":4,"riseRate":0.166667,"avgChangeRate":-0.143583},{"month":5,"riseRate":0.5,"avgChangeRate":0.044182},{"month":6,"riseRate":0.571429,"avgChangeRate":-0.038185},{"month":7,"riseRate":0.285714,"avgChangeRate":-0.066636},{"month":8,"riseRate":0.571429,"avgChangeRate":0.058864},{"month":9,"riseRate":0.142857,"avgChangeRate":-0.085295},{"month":10,"riseRate":0.428571,"avgChangeRate":0.136079},{"month":11,"riseRate":0.571429,"avgChangeRate":0.061609},{"month":12,"riseRate":0.285714,"avgChangeRate":-0.036595}],"exchange":"NASDAQ","name":"Nextcure Inc.","nameEN":"Nextcure Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.9","shortVersion":"4.35.9","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Nextcure Inc.(NXTC)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Nextcure Inc.(NXTC)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Nextcure Inc.,NXTC,Nextcure Inc.股票,Nextcure Inc.股票老虎,Nextcure Inc.股票老虎国际,Nextcure Inc.行情,Nextcure Inc.股票行情,Nextcure Inc.股价,Nextcure Inc.股市,Nextcure Inc.股票价格,Nextcure Inc.股票交易,Nextcure Inc.股票购买,Nextcure Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Nextcure Inc.(NXTC)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Nextcure Inc.(NXTC)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}